Clicky

Teva Pharmaceutical Industries Ltd(TEVA) News

Date Title
Jul 28 This is the Most Dangerous Week for Investors in 20 Years
Jul 25 S&P 500 Gains and Losses Today: Deckers Stock Jumps as Global Footprint Grows; Intel Shares Sink
Jul 24 Deckers Brands Reports First Quarter Fiscal Year 2026 Financial Results
Jul 21 EdgeOne Medical Announces Appointment of Michael Denzer as VP, Client Relations to Further Elevate Product Innovation and Client Partnerships
Jul 21 Should J&J Stock Be in Your Portfolio After Q2 Beat & Guidance Raise?
Jul 18 Trump Aims Tariff Double Whammy at Industries, Nations by Aug. 1
Jul 16 JNJ Begins Drug Sector Q2 Earnings With a Beat & Guidance Raise
Jul 14 Deckers Brands Announces Conference Call to Review First Quarter Fiscal 2026 Earnings Results
Jul 11 TEVA Stock Up More than 20% in Three Months: Buy, Sell or Hold the Stock?
Jun 17 Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy
Jun 17 Generic Drugmakers Resist Trump’s Calls for More U.S. Manufacturing
Jun 17 Teva, Fosun Pharma partner to develop TEV-56278
Jun 17 Teva to collaborate with Fosun Pharma for TEV-56278
Jun 16 Teva and Fosun Pharma Enter into a Strategic Partnership to Develop Novel Anti-PD1-IL2 Therapy (TEV-56278) in Immuno-Oncology
Jun 16 Billionaire Stanley Druckenmiller Dumped His Entire Stake in Palantir and Has Piled Into This Suddenly Unstoppable Drug Stock for 3 Straight Quarters
May 29 Teva Reaffirms “Pivot to Growth” Strategy Progress with Launch of Acceleration Phase at 2025 Innovation and Strategy Day
May 28 TEVA Begins IND-Enabling Studies on Inflammatory Disease Candidate
May 28 Billionaire Stanley Druckenmiller Just Sold One of Wall Street's Hottest Stock-Split Stocks and Is Piling Into a Promising Drugmaker Instead
May 28 Teva Pharmaceutical Industries Limited (TEVA) Wins FDA Fast Track for Celiac Disease Drug TEV-53408
May 27 Teva Celiac Disease Candidate Granted Fast Track Designation by US FDA